Coeptis Therapeutics Holdings Inc (COEPW)
$0.01
$0.00
(13.04%)
As on 24-Apr-2026 16:27EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
5 Years Aggregate
CFO
$-18.83 Mln
EBITDA
$-74.95 Mln
Net Profit
$-83.67 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Coeptis Therapeutics Holdings Inc (COEPW)
| -3.7 | -45.8 | -20.0 | -25.7 | -59.6 | -- | -- |
|
BSE Sensex*
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Coeptis Therapeutics Holdings Inc (COEPW)
| -50.7 | -29.2 | -69.0 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Coeptis Therapeutics Holdings Inc (COEPW)
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple... myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania. Read more
-
Co-Founder, Chairman, CEO & Pres
Mr. David Mehalick
-
Co-Founder, Chairman, CEO & Pres
Mr. David Mehalick
-
Headquarters
Wexford, PA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Coeptis Therapeutics Holdings Inc (COEPW)
What is the current share price of Coeptis Therapeutics Holdings Inc (COEPW) Today?
The share price of Coeptis Therapeutics Holdings Inc (COEPW) is $0.01 (NASDAQ) as of 24-Apr-2026 16:27 EDT. Coeptis Therapeutics Holdings Inc (COEPW) has given a return of -59.59% in the last 3 years.
What is the current PB & PE ratio of Coeptis Therapeutics Holdings Inc (COEPW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
0.00 |
0.00 |
2024 |
0.00 |
0.01 |
2023 |
-0.03 |
0.15 |
2022 |
0.00 |
0.02 |
2021 |
-- |
-- |
What is the 52 Week High and Low of Coeptis Therapeutics Holdings Inc (COEPW)?
The 52-week high and low of Coeptis Therapeutics Holdings Inc (COEPW) are Rs 0.05 and Rs 0.01 as of 03-Sep-2026.
What is the market cap of Coeptis Therapeutics Holdings Inc (COEPW)?
Coeptis Therapeutics Holdings Inc (COEPW) has a market capitalisation of -- as on 24-Apr-2026. As per SEBI classification, it is a company.
Should I invest in Coeptis Therapeutics Holdings Inc (COEPW)?
Before investing in Coeptis Therapeutics Holdings Inc (COEPW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.